CAMBRIDGE, Mass., February 5, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is unaware of any developments concerning the business of the Company that could account for the recent trading volatility of the Company’s common stock. The Company’s management believes it is prudent to advise the market of this given recent fluctuations of its stock price. Read more.